Please use this identifier to cite or link to this item:
|Title:||Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection||Authors:||Villar, Juan Carlos
Perez, Juan Guillermo
Cortes, Olga Lucia
Marin-Neto, José Antônio
Guyatt, Gordon H
|Issue Date:||27-May-2014||Journal:||The Cochrane database of systematic reviews||Abstract:||
Prevention of chronic chagasic cardiomyopathy (CCC) by treating infected populations with trypanocidal therapy (TT) remains a challenge. Despite a renewed enthusiasm for TT, uncertainty regarding its efficacy, concerns about its safety and limited availability remain barriers for a wider use of conventional drugs. We have updated a previous version of this review.
|Appears in Collections:||Publicaciones INP|
Show full item record
checked on Jul 4, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.